Biotech

Celgene Corporation

1

Articles

Mentioned

Top Role

Feb 27, 2026

First Mention

Feb 27, 2026

Last Mention

0.61

Relevance Score

Coverage Timeline

February 2026

Amgen’s $27.8B Horizon Buy: Betting Big on Rare Diseases, Revenue Multiples, and Pipeline Synergies Deals Mentioned

Feb 27, 2026

Just a few years back, Amgen took Otezla off Celgene’s hands at less than 8x sales.